Dobutamine 5 mg/ml solution for infusion in pre-filled syringe
Dobutamine is indicated for adults who require a positive inotropic support in the treatment of cardiac decompensation due to depressed contractility, caused by an organic heart disease or by cardiac surgery. Note: In cardiogenic shock characterised by heart failure with severe hypotension and in case of septic shock dobutamine may be useful if added to vasoconstrictors such as noradrenaline preferentially or dopamine in case of disturbed ventricular function, raised filling pressure of the ventricles and raised systemic resistance. Dobutamine may also be used for detection of myocardial ischaemia and of viable myocardium within the scope of an echocardiographic examination (dobutamine stress echocardiography), if patients cannot undergo a period of exercise or if the exercise yields no information of value. Paediatric population Dobutamine is indicated in all paediatric age groups (from neonates to 18 years of age) as inotropic support in low cardiac output hypoperfusion states resulting from decompensated heart failure, following cardiac surgery, cardiomyopathies and in cardiogenic or septic shock.